ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 184 filers reported holding ARCUS BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $9,698,068 | +105.2% | 636,774 | +154.4% | 0.00% | +100.0% |
| Q1 2024 | $4,725,909 | -58.2% | 250,313 | -57.7% | 0.00% | -50.0% |
| Q4 2023 | $11,312,758 | +7.1% | 592,291 | +0.7% | 0.00% | 0.0% |
| Q3 2023 | $10,558,334 | -13.1% | 588,208 | -1.7% | 0.00% | -33.3% |
| Q2 2023 | $12,148,122 | -17.2% | 598,135 | -25.7% | 0.00% | 0.0% |
| Q1 2023 | $14,674,700 | -6.9% | 804,534 | +5.5% | 0.00% | -25.0% |
| Q4 2022 | $15,766,846 | +69708.0% | 762,420 | -11.7% | 0.00% | -33.3% |
| Q3 2022 | $22,586 | -8.5% | 863,385 | -11.4% | 0.01% | 0.0% |
| Q2 2022 | $24,685 | -99.7% | 974,132 | +295.3% | 0.01% | +200.0% |
| Q1 2022 | $7,777,000 | +70.9% | 246,440 | +119.1% | 0.00% | +100.0% |
| Q4 2021 | $4,551,000 | +121.7% | 112,461 | +91.1% | 0.00% | – |
| Q3 2021 | $2,053,000 | -82.1% | 58,852 | -85.9% | 0.00% | -100.0% |
| Q2 2021 | $11,444,000 | -29.9% | 416,731 | -28.3% | 0.00% | -25.0% |
| Q1 2021 | $16,327,000 | -17.2% | 581,451 | -23.4% | 0.00% | -20.0% |
| Q4 2020 | $19,708,000 | +152.9% | 759,163 | +67.0% | 0.01% | +150.0% |
| Q3 2020 | $7,793,000 | -42.8% | 454,668 | -17.4% | 0.00% | -50.0% |
| Q2 2020 | $13,616,000 | +1076.8% | 550,367 | +560.3% | 0.00% | – |
| Q1 2020 | $1,157,000 | -6.5% | 83,356 | -31.9% | 0.00% | – |
| Q4 2019 | $1,237,000 | +45.5% | 122,435 | +31.0% | 0.00% | – |
| Q3 2019 | $850,000 | +15.3% | 93,453 | +0.8% | 0.00% | – |
| Q2 2019 | $737,000 | +33.8% | 92,715 | +110.0% | 0.00% | – |
| Q1 2019 | $551,000 | +27.5% | 44,152 | +10.2% | 0.00% | – |
| Q4 2018 | $432,000 | +70.1% | 40,078 | +120.0% | 0.00% | – |
| Q3 2018 | $254,000 | -28.0% | 18,215 | -36.9% | 0.00% | – |
| Q2 2018 | $353,000 | -82.3% | 28,853 | -77.6% | 0.00% | -100.0% |
| Q1 2018 | $1,992,000 | – | 129,025 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $29,404,284 | 19.15% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,864,970 | 6.40% |
| Octagon Capital Advisors LP | 2,172,000 | $39,617,280 | 5.70% |
| Boxer Capital, LLC | 1,432,200 | $26,123 | 1.28% |
| PFM Health Sciences, LP | 1,559,947 | $28,453,433 | 1.26% |
| SECTORAL ASSET MANAGEMENT INC | 293,646 | $5,356,103 | 1.03% |
| DAFNA Capital Management LLC | 175,217 | $3,195,958 | 0.96% |
| Ikarian Capital, LLC | 230,000 | $4,195,200 | 0.95% |
| Tejara Capital Ltd | 50,000 | $912,000 | 0.47% |
| Capital Impact Advisors, LLC | 20,501 | $373,938 | 0.46% |